NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancer. Schram AM, Yang SR, Kahn G, Velasco R, et al. J Natl Cancer Inst 2026;118:847-855.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schram AM, Yang SR, Kahn G, Velasco R, et al. NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancer. J Natl Cancer Inst 2026;118:847-855.
PMID: 41390931